Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
Biomolecules (2022) Vol. 12, Iss. 6, pp. 824-824
Open Access | Times Cited: 241

Showing 26-50 of 241 citing articles:

Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
Jasmine Tidwell, Natalie Balassiano, Anjiya Shaikh, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 8, pp. 1001-1012
Open Access | Times Cited: 17
Carbon Monoxide: A Second Biomarker to Couple with Viscosity for the Construction of “Dual-Locked” Near-Infrared Fluorescent Probes for Accurately Diagnosing Non-Alcoholic Fatty Liver Disease
Shaohui Han, Yuyang Zeng, Yiling Li, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 50, pp. 18619-18628
Closed Access | Times Cited: 17
Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning
Yang Cao, Yiwei Du, Weili Jia, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
Branka Filipović, Marija Marjanovic-Haljilji, Dragana Mijač, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9132-9148
Open Access | Times Cited: 16
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 6
Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study
Maria Magdalena Quetglas‐Llabrés, Margalida Monserrat-Mesquida, Cristina Bouzas, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 480-480
Open Access | Times Cited: 6
Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease
Yan Jiang, Narazah Mohd Yusoff, Jiang Du, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 7, pp. 760-772
Open Access | Times Cited: 6
Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
The multiple mechanisms and therapeutic significance of rutin in metabolic dysfunction-associated fatty liver disease (MAFLD)
Qianzhuo Wang, Yingjuan Zhang, Ruiling Lu, et al.
Fitoterapia (2024) Vol. 178, pp. 106178-106178
Closed Access | Times Cited: 5
Abnormal ac4C modification in metabolic dysfunction associated steatotic liver cells
Xiqian Zhang, Yaxian Zheng, J.-J. Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
“Evaluation of Curcuma zedoaria Rosc. in the management of non-alcoholic fatty liver Disease: A Randomized, single blind, controlled trial”
Aaqib Ashraf, Shameem Ahmad Rather, Mahvish Mehraj
Arab Journal of Gastroenterology (2025)
Closed Access
Effects of high-calorie diet-induced obesity on molecular structures of lipids and proteins - a multi-organ study using FTIR spectroscopy.
Kaja Piana, Agata Ziomber-Lisiak, Blazej Ruszczycki, et al.
Archives of Biochemistry and Biophysics (2025) Vol. 765, pp. 110325-110325
Closed Access
Implication of protein post translational modifications in gastric cancer
Houji Song, Mingze Zhang, Chengwang Guo, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Evaluation of the association between the PNPLA3 rs738409 variants with the incidence of atherosclerosis in patients with different fatty liver grades
Shaimaa Mohamed, Ghada M. Salum, Reham Ibrahim Siddik, et al.
Gene Reports (2025), pp. 102160-102160
Closed Access
Selenium Nanoparticles Decorated With Stevioside Potentially Attenuate Fructose Palmitate Induced Lipid Accumulation in HepG2 Cells
Shuai Li, Hui Yang, Ziqi Zhou, et al.
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access
The effects of HAPA theory-based case management in patients with metabolic dysfunction-associated steatotic liver disease
Mei Jia, Yan Xie, Pingping Huang, et al.
Annals of Hepatology (2025) Vol. 30, Iss. 2, pp. 101790-101790
Open Access
Remnant cholesterol, a potential risk factor of metabolic dysfunction-associated fatty liver disease
Xuanyu Hao, Dongyang Li, Xingyong Huang, et al.
Nutrition & Metabolism (2025) Vol. 22, Iss. 1
Open Access
Early‐life antibiotic exposure aggravates hepatic steatosis through enhanced endotoxemia and lipotoxic effects driven by gut Parabacteroides
Xi Zhang, Darren Chan, Jie Zhu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Targeting Histone Deacetylase 11 with a Highly Selective Inhibitor for the Treatment of MASLD
Feng Zhang, Kairui Yue, Simin Sun, et al.
Advanced Science (2025)
Open Access
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial
Mohammad Ali Mohsenpoor, Karim Parastouei, Maryam Taghdir, et al.
Journal of Health Population and Nutrition (2025) Vol. 44, Iss. 1
Open Access
Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
Chujin Cao, Mengxia Shi, Xiuru Wang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 15
Clinical effectiveness of α-lipoic acid, myo-inositol and propolis supplementation on metabolic profiles and liver function in obese patients with NAFLD: A randomized controlled clinical trial
Helda Tutunchi, Sara Arefhosseini, Mehrangiz Ebrahimi‐Mameghani
Clinical Nutrition ESPEN (2023) Vol. 54, pp. 412-420
Closed Access | Times Cited: 14
Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery
Marcelo Hatto, Victor Kenzo Ivano, Martinho Antônio Gestic, et al.
Obesity Surgery (2023) Vol. 33, Iss. 5, pp. 1580-1586
Closed Access | Times Cited: 14
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas
Henrique Souza-Tavares, Carolline Santos Miranda, Isabela Macedo Lopes Vasques-Monteiro, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4136-4155
Open Access | Times Cited: 14

Scroll to top